(c) 2024 PillSync.com

Respaire-30 (guaifenesin 150 mg pseudoephedrine hydrochloride 30 mg) Dailymed

  1. Human OTC
  2. Archived
    • May Be Discontinued
      Try Other Labelers
  3. Laser Pharmaceuticals, LLC

Generic: guaifenesin

Respaire-30 capsule - (guaifenesin 150 mg pseudoephedrine hydrochloride 30 mg) image

IMPRINT: LASER360     SHAPE: capsule
    COLOR: green

  1. FDA Adverse Reactions

Go PRO for all pill images

Active Ingredient Section


Drug facts

Active ingredients (in each immediate-release capsule) Guaifensin 150 mg  Pseudoephedine HCL 30mg

Purpose Section


Purpose  Expectorant  Nasal decongestant

Keep Out Of Reach Of Children Section


Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Indications And Uses Section


Uses

helps to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

temporarily relieves nasal congestion due to :  the common cold  hay fever  upper respiratory allergies  temporarily restores free breathing through the nose  promotes nasal and /or sinus drainage  temporarily relieves sinus congestion and pressure

Warning Section


Warnings

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

heart disease  diabetes  high blood pressure   thyroid disease  trouble urinating due to enlarged prostate gland  persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema  cough accompanied by too much phlegm (mucus)

When using this product do not use more than directed

Stop use and ask a doctor if

you get nervous, dizzy or sleepless  symptoms do not get better within 7 days, come back or occur with fever, rash or persistant headache. These could be signs of a serious illness.

Dosage And Administration Section


Directions

take with a full glass of water  this product can be administered without regard for timing of meals

adults and children 12 years of age and older  1 or 2 capsules every 4-6 hours: not more than 8 capsules in 24 hours

children 6 to under 12 years of age  1 capsule every 4-6 hours: not more than 4 capsules in 24 hours

children under 6 years of age  do not use

Inactive Ingredient Section


Inactive ingredients

corn starch, DandC yellow #10,FDandC blue #!, FDandC red #$), gelatin, iron oxide back, povidone, shellac, sugar, talc, titanium dioxide

Pregnancy Or Breast-feeding Section


If pregnant or breast-feeding, ask a health professional before use.

Other Information Section


Other information

store at 25 degrees C (77 degrees) excursions permitted between 15 degrees - 30 degrees C (59 degrees - 86 degrees F)

use by expiration date on package

Questions Section


Questions? call 1-864-286-8229, 24 hours a day

Package Display Label


LASER NDC 16477-306-01  Respaire-30  Immediate-Release Capsules

Guaifensin 150 mg  Pseudoephedrine Hydrochloride 30 mg 

NASAL DECONGESTANT  EXPECTORANT  Clears Nasal/Sinus Congestion  Thins and Loosens Mucus

100 CAPSULES

TAMPER EVIDENT:  DO NOT USE THIS PRODUCT IF THE IMPRINTED FOIL SEAL OVER THE MOUTH OF THE BOTTLE IS CUT, TORN, BROKEN, OR MISSING

Manufactured by: Time-Cap Labs, Inc. 7 Michael Avenue, Farmingdale, NY 11735  308T  0309

Manufactured for Laser Pharmaceuticals, LLC Grenville, SC 29615  Lot #:      Exp. Date: 

  PEEL HERE FOR MORE DRUG FACTS  STOP PEELING







DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site